rotaviru
one
common
mammalian
gastroenter
children
caus
diarrhea
infect
intestin
infect
virtual
human
indifferenti
villu
enterocyt
small
intestin
fect
year
age
primari
infect
aim
studi
determin
whether
cytokin
import
caus
childhood
morbid
mortal
express
mucos
cell
effect
normal
condit
rotaviru
exclus
infect
rotaviru
suscept
cultur
human
enteroenterocyt
primarili
differenti
villu
enterocyt
cyte
method
cell
pretreat
small
intestin
recent
studi
shown
alwith
variou
cytokin
challeng
rotaviru
result
interleukin
il
interferon
ifn
ifng
clearanc
mice
function
bcell
respons
requir
pretreat
led
dosedepend
resist
rotafor
immun
subsequ
infect
less
inform
viru
infect
maximum
effect
occur
hour
abbrevi
use
paper
ifn
interferon
il
interleukin
mic
mean
inhibitori
concentr
pfu
peroxidas
focu
unit
ifn
g
abl
modul
intestin
epitherrv
rhesu
rotaviru
sd
sodium
dodecyl
sulfat
tnf
tumor
nelial
barrier
function
electrophysiolog
increas
crosi
factor
enterocyt
surfac
express
molecul
major
american
gastroenterolog
associ
avail
regard
nonspecif
host
defens
mechaof
pretreat
wherea
detect
inhibit
ocnism
rotaviru
may
import
precur
hour
pretreat
liposom
transfect
singleshel
doubleshel
rotaviru
parvent
sever
diseas
naiv
host
varieti
cytoticl
bypass
block
rotaviru
replic
kine
particularli
ifn
shown
mediat
ifngand
ifnatr
cell
bind
studi
purifi
metabol
label
rotavihost
defens
mucos
viral
pathogen
ru
show
signific
differ
among
ifngand
well
character
studi
effect
variou
cytokin
clude
abil
form
polar
monolay
welldevelop
microvilli
express
digest
ent
zyme
sucraseisomaltas
lactas
intestin
epithelium
serv
barrier
protect
host
noxiou
organ
moleabl
transport
water
ion
toward
basolatcul
simultan
facilit
absorpt
essener
aspect
also
highli
permiss
rotaviti
nutrient
recent
number
investig
ru
whether
cytokin
known
secret
shown
enterocyt
activ
particip
intercelbi
mucos
mononuclear
epitheli
cell
modul
lular
crosstalk
via
cytokin
immun
effector
cell
suscept
enterocyt
rotaviru
infect
mononuclear
cell
neutrophil
interacwa
examin
tion
allow
local
specif
modul
epitheli
immun
effector
respons
vari
condit
exampl
enterocyt
releas
variou
cytokin
incytokin
clude
interleukin
il
respons
invas
bacteal
cytokin
purchas
lyophil
powder
ria
presum
recruit
neutrophil
site
bacteship
aliquot
store
accord
supplier
recrial
invas
hand
mani
cytokin
origin
mononuclear
cell
interferon
particl
methioninefre
medium
contain
mciml
singleshel
viru
prepar
treat
methionin
cell
gift
john
barnard
vanmmol
ethylenediaminetetraacet
acid
edta
use
derbilt
univers
cell
obtain
american
ensur
remov
outer
capsid
protein
edtatr
type
tissu
collect
rockvil
md
cell
grown
prepar
residu
infect
inocul
rpmi
medium
supplement
fetal
calf
serum
lma
cell
without
liposom
monolay
wash
glutamin
penicillin
streptomycin
co
incubawith
serumfre
media
incub
hour
tor
cell
grown
cultur
dish
unless
mixtur
contain
mgml
lipofectin
gibcobrl
otherwis
state
cell
treat
indic
time
gaithersburg
md
dilut
csclpurifi
rotaviru
cytokin
state
concentr
fresh
media
doubleor
singleshel
particl
serumfre
media
dereach
confluenc
day
plate
control
cell
scribe
previous
cell
fed
equal
volum
given
fresh
media
without
cytokin
time
complet
fetal
bovin
serum
media
incub
cell
use
day
confluenc
studi
overnight
infect
detect
immunoperoxidifferenti
effect
fed
fresh
media
everi
day
dase
stain
cytokin
treatment
test
cytotox
caco
plate
microscop
inspect
morpholog
trypan
blue
exclus
mtt
dye
reduct
confluent
monolay
dish
cell
treat
maxim
dose
uml
ifng
wash
twice
chill
metabol
ifna
hour
pulselabel
methionin
methioninelabel
rrv
cpmwell
approxim
total
count
incorpor
compar
peroxidas
focu
unit
pfu
well
pfucel
ad
mediumtr
cell
specif
protein
incorpor
also
monolay
incub
gentl
rock
examin
lyse
cell
laemmli
sampl
buffer
hour
measur
bind
monolay
perform
sodium
dodecyl
sulfatepolyacrylamid
gel
wash
three
time
cold
serumfre
media
lyse
electrophoresi
sdspage
fluorographi
sd
count
previous
describ
condit
approxim
radiolabel
viru
bound
monolay
intern
determin
bind
slabel
viru
describ
follow
warmmonolay
plate
wash
serumfre
media
inocul
dilut
trypsin
minut
cell
treat
trypsinedta
solut
sigma
salin
minut
activ
viru
concentr
calcul
equal
approxim
infecti
unit
per
well
rotaviru
stock
actiat
wash
twice
icecold
media
contain
mmol
l
phenylmethylsulfonyl
fluorid
fetal
calf
serum
vate
treat
trypsin
type
viii
sigma
mgml
minut
infect
allow
proceed
lyse
count
control
experi
show
viru
bound
remov
condit
overnight
infect
cell
identifi
immunoperoxidas
stain
previous
describ
briefli
monomonolay
warm
gasa
wbsgastro
respons
cultur
intestin
epitheli
cell
challeng
rotaviru
also
test
releas
intestin
epithelia
infec
none
cytokin
test
show
evid
toxic
cell
concentr
use
tion
rotavirus
invas
bacteria
rel
long
pretreat
period
hour
chobi
gross
morpholog
trypan
blue
exclus
mtt
reduct
neither
ifn
effect
total
sen
provid
maximum
sensit
detect
cytokin
effect
suscept
rotaviru
count
per
minut
cpm
methionin
incorpor
cell
addit
treatment
result
summar
tabl
indic
induc
moder
rotavirusresist
ifn
caus
gross
chang
specif
sdspage
pattern
metabol
label
state
cell
dosedepend
manner
maximum
inhibit
control
wherea
protein
data
shown
addit
studi
perform
character
led
reproduc
decreas
infect
dubiou
physiolog
signific
maximum
inhibit
time
cours
natur
antivir
effect
figur
show
effect
differ
durat
ifna
although
synergi
effect
express
acutephas
protein
cell
ifng
pretreat
rotaviru
resist
typic
experi
sixhour
ifn
treatment
cacoha
observ
addit
effect
note
cell
treat
cytokin
cell
signific
effect
rotaviru
infect
hour
rotaviru
resist
evid
revari
concentr
checkerboard
simultan
titrat
data
shown
ifng
ifna
prequir
higher
concentr
ifng
mean
inhibitori
concentr
mic
uml
compar
treatment
led
signific
dosedepend
resist
rotaviru
infect
maximum
inhibit
mic
approxim
uml
hour
treatment
resist
rotaviru
larg
persist
respect
similar
result
obtain
cytokinepretr
cell
challeng
even
cytokin
remov
hour
cell
previous
treat
hour
similar
rotaviru
tabl
ifnand
induc
rotaviru
resist
complet
abrog
addit
time
cours
result
obtain
treatment
cell
data
shown
rotaviru
appropri
neutral
antibodi
affect
addit
control
antibodi
data
shown
vivo
typic
infect
differenti
villu
tip
cell
small
intestin
ifn
affect
ifnand
induc
rotaviru
resist
also
abrog
presenc
cycloheximid
mgml
cell
differenti
studi
effect
state
differenti
cell
antivir
first
hour
ifn
treat
gasa
wbsgastro
state
induc
ifng
ifna
differenti
thu
transfect
ifngtreat
cell
virtual
inhibit
viral
replic
cell
toward
phenotyp
characterist
increas
similar
differenti
villu
tip
enterocyt
within
rang
ifng
concentr
test
figur
product
new
viral
antigen
time
plate
studi
differenti
cell
express
approxim
measur
immunoperoxidas
stain
assay
lack
inhibit
observ
indic
alkalin
phosphatas
undifferenti
cell
treat
monolay
cacocondit
ifng
treatment
signific
effect
rotaviru
transcript
translat
cell
cell
either
day
earli
confluenc
day
differenti
plate
variou
concentr
doubleshel
infecti
rotaviru
virion
becom
transcript
activ
lose
outer
capof
ifn
hour
challeng
wa
rotaviru
ifn
induc
rotaviru
sid
uncoat
therefor
essenti
earli
step
rotaviru
replic
cycl
uncoat
defect
resist
cell
regardless
differenti
statu
differenti
cell
consispres
ifntreat
cell
would
expect
doubleshel
particl
unabl
infect
tentli
significantli
sensit
ifng
lower
concentr
ifn
test
uml
differth
cell
determin
whether
viral
uncoat
inhibit
ifng
similar
liposom
transfect
enc
note
effect
ifna
two
popul
cell
interestingli
perform
doubleshel
rotaviru
particl
figur
like
singleshel
particl
doubleshel
partither
signific
differ
rotaviru
suscept
mediatr
control
cle
fulli
infecti
ifngtreat
cell
introduc
cell
via
liposom
cell
figur
success
rotaviru
lipofect
cell
singleand
doubleshel
rotaviru
particl
studi
ifninduc
antivialso
perform
ifng
treat
ral
state
describ
inhibit
viral
transcript
cell
data
shown
translat
lipofect
singleshel
rotaviru
also
limit
rotaviru
replic
either
step
particl
fail
bypass
rotaviru
viral
life
cycl
determin
cation
liposom
resist
ifnatr
cell
use
transfect
viral
particl
cell
method
previous
use
induc
product
rotaviru
infect
ifna
also
potent
inhibitor
rotaviru
replic
tabl
singleshel
rotaviru
natur
nonpermiss
murin
lcell
fibroblast
singleshel
noninfecti
rotaviru
particl
particl
transfect
ifna
treat
cell
gasa
wbsgastro
ident
fashion
unlik
ifng
pretreat
cell
fail
bypass
ifna
rotaviru
inhibit
cell
data
shown
neither
ifng
ifna
figur
doubleshel
rotaviru
particl
also
signific
effect
rotaviru
bind
cell
uncoat
transcript
translat
block
ifngand
cell
deduc
inhibit
must
caus
earli
step
viral
replic
identifi
earli
step
bind
studi
perform
use
purifi
metabol
label
rrv
rotaviru
result
typic
experi
shown
tabl
signific
differ
radiolabel
viru
bind
control
ifna
ifngtreat
cell
could
observ
mani
purifi
rotaviru
particl
may
capabl
initi
infect
possibl
ifn
reduc
bind
infecti
fraction
rotaviru
particl
therefor
bind
infecti
particl
rrv
wa
rotaviru
also
measur
use
previous
describ
method
seen
tabl
approach
fail
show
result
express
percentag
mediatr
control
well
infect
manner
doubleshel
particl
lipofectinsingleshel
particl
kine
particularli
ifna
ifng
could
downregul
rotaviru
permiss
cell
tabl
experi
exclud
possibl
viru
allow
bind
ifng
ifna
cytokinelik
substanc
could
releas
enand
mocktreat
monolay
hour
bind
terocyt
respons
ifn
mediat
monolay
wash
warm
hour
surfacebound
viru
remov
trypantivir
effect
sinedta
intern
count
per
minut
de
time
cours
develop
antivir
state
termin
scintil
count
result
show
onset
approxim
hour
peak
hour
inhibit
rotaviru
intern
cell
ure
similar
observ
develop
pretreat
uml
ifng
figur
ifngor
chang
enterocyt
phenothi
quit
similar
level
inhibit
viral
type
decreas
stimul
cl
secret
marepl
found
similar
dose
ifng
figur
jor
histocompat
complex
express
time
suggest
poor
intern
viru
cours
also
compat
previous
describ
ifnmajor
block
rotaviru
replic
ifngtreat
induc
antivir
state
surpris
observ
ifn
induc
strong
antivir
state
cell
given
ifn
origin
discov
describ
name
antivir
effect
type
ifn
ifna
believ
inhibit
viral
translat
sever
pathway
includ
inactiv
eukaryot
initi
factor
phosphoryl
via
induc
kinas
thu
earli
studi
type
ifninduc
antivir
state
transfect
viral
rna
fail
caus
cellular
infect
previou
experi
liposom
transfect
rotaviru
fail
ifnatr
cell
confirm
result
figur
antivir
properti
ifng
type
ii
ifn
studi
less
type
ifn
ifna
ifng
bind
distinct
receptor
appar
induc
distinct
antivir
state
fact
anti
figur
procedur
redissolv
laemmli
sampl
buffer
residu
radioact
determin
scintil
count
sult
control
level
transcript
translat
new
viral
antigen
detect
immunoperoxidas
assay
conclud
inhibit
viral
transcript
andor
translat
import
toskelet
element
either
may
relev
ifngor
rotaviru
resist
proto
mechan
cellular
resist
preduct
new
viral
antigen
transfect
cell
also
viousli
describ
modif
cellular
suscept
show
antivir
effect
caus
nonspeto
rotaviru
cytoskelet
inhibitor
studi
cific
cytotox
effect
cytokin
studi
viral
cytochalasin
b
capabl
enhanc
susceptibind
entri
cytokinetr
cell
show
biliti
normal
resist
murin
l
cell
rotaviru
ifngand
viral
resist
neither
cytochalasin
taxol
cholcin
abil
account
failur
bound
rotaviru
inhibit
rotaviru
infect
permiss
cell
line
enter
cell
figur
studi
directli
address
vivo
role
ifninduc
resist
entri
invas
bacteria
ifn
cytokin
host
defens
enter
note
previous
whitikerdowl
et
al
viral
pathogen
previou
human
anim
studi
describ
type
ifninduc
reduct
vesicular
stoof
rotaviru
gastroenter
type
ifn
detect
matiti
viru
cell
entri
murin
local
system
level
compar
higher
fibroblast
cell
line
effect
much
less
prothan
use
experi
exogen
nounc
requir
much
higher
dose
ifn
ifna
report
therapeut
rotaviru
thu
potent
novel
mechan
ifngindiarrhea
piglet
calv
found
duce
antivir
state
may
applic
cell
normal
inflam
intestin
tissu
level
virus
present
studi
fact
ifngpretr
rang
ngml
normal
tissu
ngml
caco
cell
equal
resist
astroviru
comin
tissu
activ
coliti
elev
intestin
level
plete
unrel
agent
viral
diarrhea
serotyp
messeng
rna
detect
rota
lang
reoviru
bass
unpublish
observ
viru
infect
mice
number
murin
strain
r
barrier
cell
entri
rotaviru
ifngand
shaw
person
commun
decemb
basal
caco
cell
unclear
rotavirus
unlik
level
ifng
similar
use
studi
astrovirus
reovirus
infect
cell
endocytosisreadili
detect
noninflam
intestin
tissu
viindepend
direct
membran
penetr
ifng
ral
infect
could
induc
increas
intestin
level
report
induc
chang
cellular
memifng
vivo
natur
killer
cell
rotavirusspecif
cell
shown
secret
ifng
brane
lipid
composit
chang
cellular
cy
